Dishman Carbogen Amcis Limited (NSE:DCAL)
244.65
-9.60 (-3.78%)
Aug 1, 2025, 3:30 PM IST
Dishman Carbogen Amcis Employees
Dishman Carbogen Amcis had 1,132 employees as of March 31, 2024. The number of employees decreased by 163 or -12.59% compared to the previous year.
Employees
1,132
Change (1Y)
-163
Growth (1Y)
-12.59%
Revenue / Employee
23.95M INR
Profits / Employee
28.62K INR
Market Cap
38.36B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 1,132 | -163 | -12.59% |
Mar 31, 2023 | 1,295 | 127 | 10.87% |
Mar 31, 2022 | 1,168 | 239 | 25.73% |
Mar 31, 2021 | 929 | -351 | -27.42% |
Mar 31, 2020 | 1,280 | 337 | 35.74% |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 10,542 |
Cipla | 30,313 |
Apollo Hospitals Enterprise | 83,147 |
Mankind Pharma | 26,978 |
Zydus Lifesciences | 27,917 |
Fortis Healthcare | 12,237 |
Aurobindo Pharma | 26,015 |
Dishman Carbogen Amcis News
- 7 weeks ago - Dishman Carbogen clears US FDA inspection at Naroda facility with no observations - Business Upturn
- 2 months ago - Dishman Carbogen shares in focus after Swiss subsidiary signs CHF 25 million co-investment agreement - Business Upturn
- 2 months ago - Dishman Carbogen Amcis shares surge over 11% as company swings to profit in Q4, EBITDA margin doubles - Business Upturn
- 4 months ago - Dishman Carbogen shares surge 5% after arm gets drug manufacturing licence In China - Business Upturn
- 4 months ago - Dishman Carbogen Amcis subsidiary receives drug manufacturing license in China - Business Upturn
- 5 months ago - Dishman Carbogen Amcis shares jump nearly 2% after board approves Rs 50 crore debenture issuance - Business Upturn
- 6 months ago - Q3 2025 Dishman Carbogen Amcis Ltd Earnings Call Transcript - GuruFocus
- 7 months ago - Dishman Carbogen subsidiary successfully completes Swissmedic inspection of its Vionnaz facility - Business Upturn